LYRM2 抗体 (AA 1-88) (Biotin)
Quick Overview for LYRM2 抗体 (AA 1-88) (Biotin) (ABIN7158671)
抗原
See all LYRM2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-88
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human LYR motif-containing protein 2 protein (1-88AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - LYRM2 (LYR Motif Containing 2 (LYRM2))
- 
                                            别名
- LYRM2
- 
                                            背景
- 2610208E05Rik antibody, DJ122O8.2 antibody, FLJ18193 antibody, FLJ18317 antibody, FLJ21130 antibody, LYR motif-containing protein 2 antibody, lyrm2 antibody, LYRM2_HUMAN antibody, MGC104253 antibody, RP23-301P13.1 antibody
- 
                                            UniProt
- Q9NU23
 抗原
- 
                    
 
                                     
                                     
                                    